The Laboratoire Ethnodyne
Publications & Patents
The Ethnodyne company is already holding very well and has a portfolio of 8 patents.
THE 8 PATENTS OF THE ETHNODYNE LABORATORY
1 publication and 1 process patent with claims in the field of angiogenesis and more particularly for :
- Oncology,
- Treatment of the Age-Related Macula Degeneration (ARMD): Journal of Medicinal Food
4 patents of composition in the field of Neurodegenerative diseases and more particularly for an application in the treatment of :
- Parkinson's disease: WO2016 166565 A1
- Alzheimer's disease: WO2106 150481 A1
- Neuromuscular diseases (Amyotrophic Lateral Sclerosis),
- Other pathologies related to demyelination (Multiple Sclerosis).
3 patents for new molecules in the field of Neurodegenerative diseases and more particularly Alzheimer's disease and Parkinson's disease.
ongoing clinical study
The Ethnodyne laboratory is conducting a pilot clinical study (ETHNOPARK) at the University Hospital of Strasbourg in the Neurology department (pathology of movement) to evaluate the effectiveness of a composition of Parkinson's disease and associated disorders.
The results of the study are expected for the first quarter of 2019.
The laboratory Ethnodyne has developed and markets a range of 5 food supplements: